Genxiong Tang Selected Research

pyrroloquinoline

1/2022

Pyrroloquinoline quinone inhibits ligature-induced alveolar bone loss through regulation of redox balance and cell senescence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Genxiong Tang Research Topics

Disease

2	Neoplasms (Cancer) 12/2019 - 11/2019
1	Periodontitis 01/2022
1	Alveolar Bone Loss 01/2022
1	Laryngeal Neoplasms (Laryngeal Cancer) 11/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Carcinoma (Carcinomatosis) 10/2018

Drug/Important Bio-Agent (IBA)

2	Membrane Proteins (Integral Membrane Proteins)IBA 11/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 12/2019 - 11/2019
2	Surface Antigens (Surface Antigen)IBA 12/2019 - 10/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	pyrroloquinolineIBA 01/2022
1	AntioxidantsIBA 01/2022
1	Quinine (Quinson)FDA Link 01/2022
1	CytokinesIBA 01/2022
1	PQQ Cofactor (Pyrroloquinoline Quinone)IBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2020
1	SphingolipidsIBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2019
1	Messenger RNA (mRNA)IBA 11/2019
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2018

Therapy/Procedure

1	Ligation 01/2022